Explore our certified pharmaceutical, cosmetic, and edible-grade sodium hyaluronate formulations trusted by global biomedical manufacturers.
The global demand for high-purity biopolymer raw materials is scaling rapidly, driven by therapeutic and aesthetic technological shifts. Injectable Hyaluronic Acid (HA) sits at the intersection of medical device development, clinical rheumatology, ophthalmic surgery, and minimally invasive cosmetics. As premium suppliers, we provide the industrial consistency, low endotoxin thresholds, and reliable rheology profiles required for regulatory filings worldwide.
Our entire portfolio of sodium hyaluronate is synthesized via advanced bacterial fermentation (non-animal source, typically using Streptococcus equi subsp. zooepidemicus on vegan-certified mediums). This avoids the immunogenic risks associated with avian sources (rooster combs) and guarantees structural purity appropriate for clinical injections.
With an annual production footprint supplying partners across the EU, the Americas, and APAC, we address the critical pain points of high-volume procurement: regulatory batch uniformity, stable viscosity indexes under shear stress, and documentation support including Drug Master Files (DMF).
How we manipulate molecular weights and chemical structures to provide customized rheology for diverse biomedical applications.
For long-lasting dermal fillers, raw sodium hyaluronate undergoes cross-linking via 1,4-butanediol diglycidyl ether (BDDE). This reaction forms covalent ether bonds between the HA chains, turning linear polymers into stable, enzymatically resistant hydrogels. We supply both raw injection materials and pre-crosslinked formulations optimized for targeted clinical persistence.
Our engineering processes dynamically adjust the storage modulus (G', representing elastic behavior) and loss modulus (G", representing viscous flow). This allows our partners to formulate products with the precise injection extrusion force, lift capacity, and tissue integration dynamics required for varying depths of skin tissue.
Different clinical outcomes demand distinct molecular structures. We produce High Molecular Weight (HMW) HA (>2.0 MDa) for joint lubrication and ophthalmic cushion effects, Medium Molecular Weight (1.0-1.8 MDa) for traditional fillers, and Low/Ultra-Low Molecular Weight (<100 kDa) for advanced dermal mesotherapy and topical formulations.
A trusted global supplier of cosmetic, food, and pharmaceutical grade Sodium Hyaluronate with robust production capacities and rigorous quality systems.
At Suzhou Wanfukang Chemical Co., Ltd, we specialize in high-purity biopolymer supply chains. Our production facilities operate under strict GMP compliance, producing customized and standard-grade Sodium Hyaluronate powders and aqueous solutions. Our global logistics networks ensure prompt shipping with complete documentation, satisfying rigorous audits by pharmaceutical manufacturers and cosmetics developers alike.
From operating rooms to aesthetic clinics, we align product characteristics to clinical realities across diverse geographical markets.
Ophthalmic operations like cataract removal require highly viscous, cohesive sodium hyaluronate solutions. Our GMP-certified raw materials maintain space in the anterior chamber while protecting delicate corneal endothelial cells from surgical mechanical trauma.
Used extensively for knee osteoarthritis viscosupplementation. The polymer chain must mimic natural synovial fluid, possessing both shock absorption during impact and lubricating properties during slow movement. Our raw materials deliver predictable elastic profiles under load.
Aesthetic brands require varied particle sizes and swelling ratios to target different structural zones. Whether formulating deep supraperiosteal volumizers or superficial lip enhancers, our cross-linkable HA powders provide the foundational safety, low BDDE residue, and longevity required.
Exporting biocompatible materials globally requires adhering to localized regulatory paradigms. We provide complete technical files to support registration procedures under the European Union Medical Device Regulation (EU MDR), US Food and Drug Administration (FDA) 510(k) clearances, and India’s Central Drugs Standard Control Organisation (CDSCO). Every shipment includes validation for endotoxins (LAL gel clot test), residual protein values, heavy metal limits, and microbiological purity checks.
Browse our target-specific materials categorized by structural and functional classifications.
Why leading pharmaceutical and cosmetic companies select Wanfukang for localized distribution and compliance support.
India's pharmaceutical and wellness sectors have witnessed significant expansion. As Indian cosmetics and therapeutic injection manufacturers seek high-quality bulk supplies, Chinese manufacturers offering extensive documentation, competitive pricing, and strict GMP certifications have become preferred suppliers.
Read Full Insight →Faced with rising consumer expectations for high-performance topical and injection hydration solutions, major personal care formulation brands in India rely heavily on sodium hyaluronate. They choose specific molecular weights to develop target formulations with proven efficacy.
Read Full Insight →Exploring the evolution of active ingredients from luxury serum brands to mainstream pharmaceutical ointments. The flexibility of raw hyaluronic acid forms provides product formulators with optimal textures, stability profiles, and long-term shelf life.
Read Full Insight →How our ongoing research and development aligns with future bio-polymer application spaces.
Reducing active BDDE residue levels below the detection limit of 1 ppm while maintaining highly stable polymer network density. This minimizes risk profile variations in aesthetic implant formulations.
Synthesizing compound matrix formulations containing Polynucleotides (PN/PDRN) or Collagen linked directly with Hyaluronic Acid. This creates dual-action tissue regeneration matrices.
Manipulating intra-chain molecular topology to program precise degradation periods. This allows medical developers to construct drug-release matrices that degrade predictably over 3 to 12 months.
Ensure superior formulation quality with our certified premium injection grade Sodium Hyaluronate range.
Critical technical and regulatory questions answered by our biomedical research department.
Injection-grade Sodium Hyaluronate undergoes highly rigorous purification processes. It must feature extremely low endotoxin levels (typically <0.05 IU/mg, tested via Limulus Amebocyte Lysate (LAL) method) to prevent pyrogenic reactions post-injection. The level of residual proteins, nucleic acids, and heavy metals must be kept at minimal thresholds. Conversely, cosmetic-grade HA allows for higher endotoxin limits and is designed exclusively for topical formulations.
Linear (non-crosslinked) Hyaluronic Acid is rapidly broken down by endogenous hyaluronidase enzymes within 24 to 48 hours in the body. Chemical cross-linking introduces covalent bonds (e.g., using BDDE) that bridge the polymer chains together, forming a 3D macromolecular hydrogel. This network blocks enzyme access points, extending the implant duration in tissue from 6 to 18 months, depending on the cross-linking density.
Yes. Our fermentation and purification facilities are fully equipped to synthesize customized molecular weights. Whether your project requires ultra-low molecular weight (<10 kDa) for transdermal penetration studies or ultra-high molecular weight (>3.0 MDa) for synovial fluid visco-supplement formulations, we can adjust parameters to match your targeted specifications.
We provide a comprehensive analytical documentation pack with each batch. This includes the Certificate of Analysis (CoA), GMP Compliance Statements, Material Safety Data Sheets (MSDS), TSE/BSE-free certification, microbiological assay results, and stability data sheet reports to streamline global regulatory filings.
Providing seamless bulk supplies to leading laboratories, hospitals, and cosmetics houses worldwide.
